LifePoint Hospitals price target raised to $66 from $55 at Cantor Cantor increased its price target on LifePoint after the company reported better than expected Q2 results. The firm thinks the company is benefiting from larger, more urban hospitals, reform and acquisitions. However, it keeps a Hold rating on the shares.
News For LPNT From The Last 14 Days
Check below for free stories on LPNT the last two weeks.